A. A. GROM Et Al. , "Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab," ARTHRITIS & RHEUMATOLOGY , vol.68, no.1, pp.218-228, 2016
GROM, A. A. Et Al. 2016. Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab. ARTHRITIS & RHEUMATOLOGY , vol.68, no.1 , 218-228.
GROM, A. A., Ilowite, N. T., PASCUAL, V., BRUNNER, H. I., MARTINI, A., LOVELL, D., ... RUPERTO, N.(2016). Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab. ARTHRITIS & RHEUMATOLOGY , vol.68, no.1, 218-228.
GROM, SEZA Et Al. "Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab," ARTHRITIS & RHEUMATOLOGY , vol.68, no.1, 218-228, 2016
GROM, SEZA Et Al. "Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab." ARTHRITIS & RHEUMATOLOGY , vol.68, no.1, pp.218-228, 2016
GROM, A. A. Et Al. (2016) . "Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab." ARTHRITIS & RHEUMATOLOGY , vol.68, no.1, pp.218-228.
@article{article, author={SEZA ÖZEN Et Al. }, title={Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2016, pages={218-228} }